AMGN filing: Insider plans sale of 54,792 shares

Amgen reports a Form 144 notice to sell 54,792 common shares.

Rhea-AI Filing Summary

Amgen reports a Form 144 notice to sell 54,792 common shares. The filing lists two equity compensation grants as the sources: 05/01/2017 grant for 24,291 shares and 04/27/2018 grant for 30,501 shares. The proposed transactions are described as cash sales and dated 02/26/2026.

Insights

Corporate Governance Expert

Form 144 notifies the market of a proposed Rule 144 resale of 54,792 common shares.

The filing lists two equity compensation grants as the sources: 05/01/2017 for 24,291 shares and 04/27/2018 for 30,501 shares. The method is shown as cash sales, with the submission date of 02/26/2026.

These notices are administrative disclosures required before certain resales; actual sale timing and proceeds depend on holder decisions and Rule 144 conditions. Subsequent filings will show executed transactions if sales occur.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the AMGN Form 144 disclose?

The filing discloses a proposed resale of 54,792 Amgen common shares. It lists 24,291 and 30,501 shares tied to equity grants dated 05/01/2017 and 04/27/2018, respectively, with a filing date of 02/26/2026.

Who is listed as the filer on the AMGN Form 144?

The filer is recorded with Pershing Advisor Solutions at One Pershing Plaza, Jersey City. The notice shows brokerage handling of the proposed resale rather than identifying a selling individual explicitly.

Are the proposed AMGN sales cash or noncash transactions?

The Form 144 identifies the planned transactions as cash sales. The filing lines for both listed grants specify 'Cash' as the transaction type on 02/26/2026.

Does this Form 144 mean the shares have already been sold?

No; a Form 144 is a notice of intent to sell under Rule 144. It does not confirm completion. Actual sales would be reported in subsequent transaction filings if and when executed.

What grant sources are tied to the shares in the AMGN filing?

The shares are tied to equity compensation grants: an 2016 Stock Option Grant with grant dates 05/01/2017 (24,291 shares) and 04/27/2018 (30,501 shares), totaling 54,792 shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/27/2026 - 12:20 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001677950
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	AMGEN INC
SEC File Number	001-37702
Address of Issuer	ONE AMGEN CENTER DRIVE THOUSAND OAKS CALIFORNIA 91320
Phone	(805)447-1000
Name of Person for Whose Account the Securities are To Be Sold	Santos Esteban
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Associate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Pershing Advisor Solutions One Pershing Plaza JERSEY CITY NJ 07399	54792	20772598.00	539067675	02/26/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/01/2017	Equity Compensation 2016 Stock Option Grant	Issuer			30501	02/26/2026	Cash
Common	04/27/2018	Equity Compensation 2016 Stock Option Grant	Issuer			24291	02/26/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	02/27/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Esteban Santos
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)